Conventional metastatic prostate cancer models simply aren’t adequate for many therapeutic evaluations, while novel treatment strategies increasingly rely on the natural activity of living, human immune systems. Humanized mice are far more effective at modeling hormonal and immune therapies.

Modeling Prostate Cancer Therapies with Humanized Mice

Join Dr. Steven Kregel, postdoctoral fellow at the University of Michigan’s Chinnaiyan Lab, as he discusses their work establishing a humanized immune system model of metastatic prostate cancer.

Watch this webinar to:

• Learn why conventional in vivo models have proved inadequate for metastatic prostate cancer modeling
  
  
• Explore new applications for humanized mice in the study of tumor-immune interactions
  
  
• Discover how humanized immune system models can advance drug discovery research with more clinically relevant efficacy studies

Webinar Preview

Presenter

Dr. Steven Kregel is a postdoctoral fellow at the University of Michigan’s Chinnaiyan Lab, which studies basic cancer biology to discover novel biomarkers and therapeutic agents. His own work focuses on the functional and mechanistic development of novel androgen receptor therapeutics and the improved preclinical prostate cancer models.

Watch Now »